Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … Journal of Cancer, 2023 - Wiley Online Library
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … Journal of Cancer, 2023 - europepmc.org
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … journal of cancer, 2023 - pubmed.ncbi.nlm.nih.gov
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … Journal of Cancer, 2023 - inria.hal.science
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B ALLIGNET… - … Journal of Cancer, 2023 - hal.univ-reunion.fr
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B ALLIGNET… - International Journal of …, 2023 - hal.science
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - International Journal of …, 2023 - hal.univ-smb.fr
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … Journal of Cancer, 2023 - udl.hal.science
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … Journal of Cancer, 2023 - hal-ciheam.iamm.fr
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective …
P Marolleau, D Tougeron, B Allignet… - … Journal of Cancer, 2023 - hal.umontpellier.fr
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …
instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known …